AKBA – Akebia Therapeutics Inc.
Name :
Sector :
Industry:
Mark. Cap: $0.0000
EPSttm :
Float Short %
6.9
Margin Of Safety %
Put/Call OI Ratio
0.23
EPS Next Q Diff
0.05
EPS Last/This Y
EPS This/Next Y
0.12
Price
1.79
Target Price
7.17
Analyst Recom
1
Performance Q
Relative Volume
1.84
Beta
0.91
Ticker: AKBA
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-01-23 | AKBA | 2.39 | 0.22 | 0.08 | 24857 |
| 2025-01-24 | AKBA | 2.38 | 0.22 | 0.13 | 25888 |
| 2025-01-27 | AKBA | 2.3 | 0.23 | 0.14 | 26033 |
| 2025-01-28 | AKBA | 2.28 | 0.23 | 0.07 | 25999 |
| 2025-01-29 | AKBA | 2.3 | 0.23 | 0.04 | 26022 |
| 2025-01-30 | AKBA | 2.3 | 0.23 | 0.02 | 26171 |
| 2025-01-31 | AKBA | 2.23 | 0.23 | 0.34 | 26160 |
| 2025-02-03 | AKBA | 2.12 | 0.25 | 0.12 | 26355 |
| 2025-02-04 | AKBA | 2.13 | 0.25 | 0.10 | 26634 |
| 2025-02-05 | AKBA | 2.17 | 0.25 | 1.67 | 26566 |
| 2025-02-06 | AKBA | 2.16 | 0.26 | 0.13 | 26666 |
| 2025-02-07 | AKBA | 2.14 | 0.26 | 0.12 | 26681 |
| 2025-02-10 | AKBA | 2.11 | 0.25 | 0.15 | 27256 |
| 2025-02-11 | AKBA | 2.1 | 0.25 | 0.01 | 27321 |
| 2025-02-12 | AKBA | 2.12 | 0.25 | 0.00 | 27402 |
| 2025-02-13 | AKBA | 2.14 | 0.25 | 0.00 | 27479 |
| 2025-02-14 | AKBA | 2.12 | 0.24 | 0.00 | 28753 |
| 2025-02-18 | AKBA | 2.08 | 0.24 | 0.02 | 28766 |
| 2025-02-19 | AKBA | 1.97 | 0.24 | 0.01 | 28732 |
| 2025-02-20 | AKBA | 1.9 | 0.22 | 0.21 | 30222 |
| 2025-02-21 | AKBA | 1.795 | 0.23 | 0.26 | 31143 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-01-23 | AKBA | 2.39 | 0.0 | - | -0.26 |
| 2025-01-24 | AKBA | 2.38 | 0.0 | - | -0.26 |
| 2025-01-27 | AKBA | 2.30 | 0.0 | - | -0.26 |
| 2025-01-28 | AKBA | 2.29 | 0.0 | - | -0.26 |
| 2025-01-29 | AKBA | 2.30 | 0.0 | - | -0.26 |
| 2025-01-30 | AKBA | 2.30 | 0.0 | - | -0.26 |
| 2025-01-31 | AKBA | 2.23 | 0.0 | - | -0.26 |
| 2025-02-03 | AKBA | 2.12 | 0.0 | - | -0.26 |
| 2025-02-04 | AKBA | 2.14 | 0.0 | - | -0.26 |
| 2025-02-05 | AKBA | 2.16 | 0.0 | - | -0.26 |
| 2025-02-06 | AKBA | 2.16 | 0.0 | - | -0.26 |
| 2025-02-07 | AKBA | 2.14 | 0.0 | - | -0.26 |
| 2025-02-10 | AKBA | 2.10 | 0.0 | - | -0.26 |
| 2025-02-11 | AKBA | 2.10 | 0.0 | - | -0.26 |
| 2025-02-12 | AKBA | 2.12 | 0.0 | - | -0.26 |
| 2025-02-13 | AKBA | 2.14 | 0.0 | - | -0.26 |
| 2025-02-14 | AKBA | 2.13 | 0.0 | - | -0.26 |
| 2025-02-18 | AKBA | 2.07 | 0.0 | - | -0.26 |
| 2025-02-19 | AKBA | 1.98 | 0.0 | - | -0.26 |
| 2025-02-20 | AKBA | 1.90 | 0.0 | - | -0.26 |
| 2025-02-21 | AKBA | 1.79 | 0.0 | - | -0.26 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-01-23 | AKBA | 0.00 | 6.46 | 8.03 |
| 2025-01-24 | AKBA | 0.00 | 6.46 | 8.03 |
| 2025-01-27 | AKBA | 0.00 | 6.57 | 8.03 |
| 2025-01-28 | AKBA | 0.00 | 6.57 | 8.67 |
| 2025-01-29 | AKBA | 0.00 | 6.57 | 8.67 |
| 2025-01-30 | AKBA | 0.00 | 6.57 | 8.67 |
| 2025-01-31 | AKBA | 0.00 | 6.57 | 8.67 |
| 2025-02-03 | AKBA | 0.00 | 6.34 | 8.67 |
| 2025-02-04 | AKBA | 0.00 | 6.34 | 8.67 |
| 2025-02-05 | AKBA | -2.58 | 6.34 | 8.67 |
| 2025-02-06 | AKBA | -2.58 | 6.34 | 8.67 |
| 2025-02-07 | AKBA | -2.58 | 6.34 | 8.67 |
| 2025-02-10 | AKBA | -2.58 | 6.83 | 8.72 |
| 2025-02-11 | AKBA | -2.34 | 6.83 | 8.72 |
| 2025-02-12 | AKBA | -2.34 | 6.83 | 7.00 |
| 2025-02-13 | AKBA | -2.34 | 6.83 | 7.00 |
| 2025-02-14 | AKBA | -2.34 | 6.83 | 7.00 |
| 2025-02-18 | AKBA | -2.34 | -0.32 | 7.00 |
| 2025-02-19 | AKBA | -2.34 | -0.32 | 7.00 |
| 2025-02-20 | AKBA | -2.34 | -0.32 | 7.00 |
| 2025-02-21 | AKBA | -3.11 | -0.32 | 6.90 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.1
Avg. EPS Est. Current Quarter
-0.04
Avg. EPS Est. Next Quarter
-0.06
Insider Transactions
-3.11
Institutional Transactions
-0.32
Beta
0.91
Average Sales Estimate Current Quarter
40
Average Sales Estimate Next Quarter
37
Fair Value
Quality Score
22
Growth Score
35
Sentiment Score
41
Actual DrawDown %
86.9
Max Drawdown 5-Year %
-98.2
Target Price
7.17
P/E
Forward P/E
PEG
P/S
2.31
P/B
P/Free Cash Flow
EPS
-0.22
Average EPS Est. Cur. Y
-0.26
EPS Next Y. (Est.)
-0.14
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-27.07
Relative Volume
1.84
Return on Equity vs Sector %
72
Return on Equity vs Industry %
83.4
EPS 1 7Days Diff
-0.1
EPS 1 30Days Diff
-0.06
EBIT Estimation
stock quote shares AKBA – Akebia Therapeutics Inc. Stock Price stock today
news today AKBA – Akebia Therapeutics Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch AKBA – Akebia Therapeutics Inc. yahoo finance google finance
stock history AKBA – Akebia Therapeutics Inc. invest stock market
stock prices AKBA premarket after hours
ticker AKBA fair value insiders trading